Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome

被引:7
作者
Dickson-Humphries, Tania [1 ,2 ]
Bottenberg, B. [3 ,4 ]
Kuntz, Susan [5 ]
机构
[1] PA Vasc Surg Carson Surg Grp, Carson City, NV 89703 USA
[2] Univ N Dakota, PA Program, Grand Forks, ND 58201 USA
[3] Practices Internal Med & lipidol, Carson City, NV USA
[4] Pacific Lipid Assoc, Jacksonville, FL 32216 USA
[5] Univ N Dakota, Dept Family & Community Med, PA Program, Grand Forks, ND 58201 USA
来源
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2013年 / 26卷 / 07期
关键词
type; 2; diabetes; metabolic syndrome; cardiovascular disease; atherogenic dyslipidemia; insulin resistance; MANAGEMENT; HYPERTRIGLYCERIDEMIA; TRIGLYCERIDES;
D O I
10.1097/01.JAA.0000431506.00627.be
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease remains the leading cause of death in men and women in the United States. Aggressive treatment of insulin resistance and its associated lipid abnormalities remains a top priority for preventing cardiovascular morbidity and mortality.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 14 条
[1]  
[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004]
[2]   Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population [J].
Ascaso, Juan F. ;
Millan, Jesus ;
Mateo-Gallego, Rocio ;
Ruiz, Antonio ;
Suarez-Tembra, M. ;
Borrallo, Rosa M. ;
Zambon, Daniel ;
Gonzalez-Santos, Pedro ;
Peres-de-Juan, Miguel ;
Ros, Emili .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (02) :177-181
[3]  
Ballantyne C., 2009, CLIN LIPIDOLOGY COMP
[4]  
Bonow RO., 2011, Braunwald's Heart Disease eBook: A Textbook of Cardiovascular Medicine
[5]   Optimal management of lipids in diabetes and metabolic syndrome [J].
Brown, W. Virgil ;
Clark, Luther ;
Falko, James M. ;
Guyton, John R. ;
Rees, Tomas J. ;
Schonfeld, Gustav ;
Lopes-Virella, Maria F. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2008, 2 (05) :335-342
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Regulation of plasma triglycerides in insulin resistance and diabetes [J].
Ginsberg, HN ;
Zhang, YL ;
Hernandez-Ono, A .
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (03) :232-240
[8]   Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach [J].
Inzucchi, Silvio E. ;
Bergenstal, Richard M. ;
Buse, John B. ;
Diamant, Michaela ;
Ferrannini, Ele ;
Nauck, Michael ;
Peters, Anne L. ;
Tsapas, Apostolos ;
Wender, Richard ;
Matthews, David R. .
DIABETES CARE, 2012, 35 (06) :1364-1379
[9]   Management of Hypertriglyceridemia in the Diabetic Patient [J].
Jialal, Ishwarlal ;
Amess, William ;
Kaur, Manpreet .
CURRENT DIABETES REPORTS, 2010, 10 (04) :316-320
[10]   Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial) [J].
Jones, PH ;
Davidson, MH ;
Stein, EA ;
Bays, HE ;
McKenney, JM ;
Miller, E ;
Cain, VA ;
Blasetto, JW ;
STELLAR Study Grp .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (02) :152-160